These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1692085)

  • 1. Enhancement of cytotoxicity of bleomycin by dithiocarbamates: formation of bis(dithiocarbamato) cu(II).
    Ujjani B; Lyman S; Winkelmann D; Antholine W; Petering DH; Jones MM
    J Inorg Biochem; 1990 Jan; 38(1):81-93. PubMed ID: 1692085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells.
    Lyman S; Ujjani B; Renner K; Antholine W; Petering DH; Whetstone JW; Knight JM
    Cancer Res; 1986 Sep; 46(9):4472-8. PubMed ID: 2425953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
    Viola-Rhenals M; Rieber MS; Rieber M
    Biochem Pharmacol; 2006 Mar; 71(6):722-34. PubMed ID: 16412983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipseudomonal effects of selected dithiocarbamates alone and in combination with gentamicin or aztreonam.
    Walker EM; Hardin HF; Gale GR; Reifsteck ME; Cannon DJ; Jones MM
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):101-17. PubMed ID: 2536949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) Cu(II) with Ehrlich cells. Binding of copper to metallothionein and its relationship to zinc metabolism and cell proliferation.
    Kraker A; Krezoski S; Schneider J; Minkel D; Petering DH
    J Biol Chem; 1985 Nov; 260(25):13710-8. PubMed ID: 4055754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation-reduction reactions in Ehrlich cells treated with copper-neocuproine.
    Byrnes RW; Antholine WE; Petering DH
    Free Radic Biol Med; 1992 Nov; 13(5):469-78. PubMed ID: 1334027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper(II)- and iron(II)-complexes of methyl 2-(2-aminoethyl)-aminomethyl-pyridine-6-carboxyl-histidinate (AMPHIS), a peptide mimicking the metal-chelating moiety of bleomycin. An ESR investigation.
    Hénichart JP; Bernier JL; Houssin R; Lohez M; Kenani A; Catteau JP
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1036-41. PubMed ID: 2579645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the chemical reactivity of copper bleomycin.
    Antholine WE; Solaiman D; Saryan LA; Petering DH
    J Inorg Biochem; 1982 Oct; 17(2):75-94. PubMed ID: 6184448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of bleomycin in iron- and copper-deficient cells.
    Lyman S; Taylor P; Lornitzo F; Wier A; Stone D; Antholine WE; Petering DH
    Biochem Pharmacol; 1989 Dec; 38(23):4273-82. PubMed ID: 2480795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial reaction of 3-ethyoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) copper(II) with Ehrlich ascites tumor cells.
    Minkel DT; Petering DH
    Cancer Res; 1978 Jan; 38(1):117-23. PubMed ID: 201367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper(II).bleomycin, iron(III).bleomycin, and copper(II).phleomycin: comparative study of deoxyribonucleic acid binding.
    Povirk LF; Hogan M; Dattagupta N; Buechner M
    Biochemistry; 1981 Feb; 20(3):665-71. PubMed ID: 6163448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical and ESR studies on Cu(II) complexes of bleomycin and its related compounds.
    Ishizu K; Murata S; Miyoshi K; Sugiura Y; Takita T; Umezawa H
    J Antibiot (Tokyo); 1981 Aug; 34(8):994-1000. PubMed ID: 6172410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of metallobleomycins by electronic spectroscopy, electron spin resonance spectroscopy, and potentiometric titration.
    Sugiura Y; Ishizu K; Miyoshi K
    J Antibiot (Tokyo); 1979 May; 32(5):453-61. PubMed ID: 93598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of nitric oxide and other iron-containing metabolites during the reductive metabolism of nitroprusside by microsomes and by thiols.
    Rao DN; Cederbaum AI
    Arch Biochem Biophys; 1995 Aug; 321(2):363-71. PubMed ID: 7646061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dithiocarbamates inhibit hematopoiesis via a copper-dependent mechanism.
    Pyatt DW; Yang Y; Le A; Stillman WS; Irons RD
    Biochem Biophys Res Commun; 2000 Aug; 274(2):513-8. PubMed ID: 10913369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, characterization and antitumor studies of Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes of N-salicyloyl-N'-o-hydroxythiobenzhydrazide.
    Shrivastav A; Singh NK; Singh SM
    Bioorg Med Chem; 2002 Apr; 10(4):887-95. PubMed ID: 11836095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function correlations in the reaction of bis(thiosemicarbazonato) copper(II) complexes with Ehrlich ascites tumor cells.
    Minkel DT; Saryan LA; Petering DH
    Cancer Res; 1978 Jan; 38(1):124-9. PubMed ID: 563285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESR of copper and iron complexes with antitumor and cytotoxic properties.
    Antholine WE; Kalyanaraman B; Petering DH
    Environ Health Perspect; 1985 Dec; 64():19-35. PubMed ID: 2420582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductive metalation of cyclic and acyclic pseudopeptidic bis-disulfides and back conversion of the resulting diamidato/dithiolato complexes to bis-disulfides.
    Desbenoît N; Galardon E; Frapart Y; Tomas A; Artaud I
    Inorg Chem; 2010 Sep; 49(18):8637-44. PubMed ID: 20718487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orientation of iron bleomycin and porphyrin complexes on DNA fibers.
    Chikira M; Iiyama T; Sakamoto K; Antholine WE; Petering DH
    Inorg Chem; 2000 Apr; 39(8):1779-86. PubMed ID: 12526568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.